Candid Health Lands $120M in Series D Funding

Candid Health raised $120 million in Series D funding led by Sixth Street Growth.

Oak HC/FT, 8VC, and Y Combinator also backed the round.

The company’s valuation rose to about 3x its Series C level from February 2025.

The new capital underscores investor confidence in its automated healthcare revenue cycle management platform.